Round Rock Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Round Rock Advisors's BMY Position: Q3 2026 in Review
Round Rock Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 3,538 shares — an estimated $204K sold.
Round Rock Advisors first reported a position in BMY in Q2 2022 and held it in 7 quarters. The position peaked at $411K in Q4 2022. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Round Rock Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Round Rock Advisors sold 3,538 Bristol-Myers Squibb shares in Q3 2026, an estimated $204K.
- Round Rock Advisors first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 7 quarters.
- Round Rock Advisors's Bristol-Myers Squibb position peaked at $411K in Q4 2022.
- 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Round Rock Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.